touchPODCAST

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis

touchIN CONVERSATION for touchNEUROLOGY

Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis.

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).

For further information visit our website: https://touchneurology.com/education/mdt-perspectives-on-management-of-agitation-in-alzheimers-dementia/in-conversation-lets-talk-about-AAD/

Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
• Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
• Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 
https://touchoncologyime.org/mdt-insights-systemic-mastocytosis

Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

touchPANEL DISCUSSION for touchHAEMATOLOGY 

Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
• Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
• Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 
https://touchhaematologyime.org/mdt-insights-systemic-mastocytosis

Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

touchPANEL DISCUSSION for touchDERMATOLOGY 

Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
• Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
• Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 
https://touchdermaime.org/mdt-insights-systemic-mastocytosis

Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
• Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
• Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 
https://touchimmunologyime.org/mdt-insights-systemic-mastocytosis

Immunotherapy for early-stage, resectable NSCLC

Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.

The expert

• Prof. Heather A Wakelee – Stanford University, CA, USA

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://touchrespiratoryime.org/io-early-stage-nsclc/ 

Immunotherapy for early-stage, resectable NSCLC

Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.

The expert

• Prof. Heather A Wakelee – Stanford University, CA, USA

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
https://touchoncologyime.org/io-early-stage-nsclc/

Impact of pharmacotherapies for achondroplasia – Discussion 4 / 4

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia

The multidisciplinary team and patient advocate:

MFM specialist - Prof. Karin Blakemore
Johns Hopkins University School of Medicine, Baltimore, MD, USA

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 
Otto-von-Guericke University Magdeburg, Magdeburg, Germany  

Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Patient advocate - Ms Carly Kutner
Freehold, NJ, USA

This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

Monitoring and early treatment initiation - Discussion 3

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications

The multidisciplinary team and patient advocate:

Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 
Otto-von-Guericke University Magdeburg, Magdeburg, Germany  

Patient advocate - Ms Carly Kutner
Freehold, NJ, USA

This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/